Tumor grading via least differentiation analysis was found to be a way to measure the risk of lymph node metastasis (LNM) in patients with submucosal invasive colorectal cancer (CRC). Tumor grading ...
A phase I/II trial of MEK162 in combination with gemcitabine (G) and cisplatin (C) for patients (pts) with untreated advanced biliary cancer (ABC). Combined treatment with TLR7/8 agonists and carbon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results